These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 27793046)
21. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer. Wang W; Xing C Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828 [TBL] [Abstract][Full Text] [Related]
22. TNF-α promotes invasive growth through the MET signaling pathway. Bigatto V; De Bacco F; Casanova E; Reato G; Lanzetti L; Isella C; Sarotto I; Comoglio PM; Boccaccio C Mol Oncol; 2015 Feb; 9(2):377-88. PubMed ID: 25306394 [TBL] [Abstract][Full Text] [Related]
23. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer. Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676 [No Abstract] [Full Text] [Related]
24. Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met. Satoh K; Nimura S; Aoki M; Hamasaki M; Koga K; Iwasaki H; Yamashita Y; Kataoka H; Nabeshima K Cancer Sci; 2014 Nov; 105(11):1487-95. PubMed ID: 25220207 [TBL] [Abstract][Full Text] [Related]
25. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056 [TBL] [Abstract][Full Text] [Related]
26. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
27. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Parr C; Jiang WG Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767 [TBL] [Abstract][Full Text] [Related]
28. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Galimi F; Torti D; Sassi F; Isella C; Corà D; Gastaldi S; Ribero D; Muratore A; Massucco P; Siatis D; Paraluppi G; Gonella F; Maione F; Pisacane A; David E; Torchio B; Risio M; Salizzoni M; Capussotti L; Perera T; Medico E; Di Renzo MF; Comoglio PM; Trusolino L; Bertotti A Clin Cancer Res; 2011 May; 17(10):3146-56. PubMed ID: 21447729 [TBL] [Abstract][Full Text] [Related]
29. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979 [TBL] [Abstract][Full Text] [Related]
30. BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs. Liu Z; Wei P; Yang Y; Cui W; Cao B; Tan C; Yu B; Bi R; Xia K; Chen W; Wang Y; Zhang Y; Du X; Zhou X Clin Cancer Res; 2015 Apr; 21(7):1752-63. PubMed ID: 25762344 [TBL] [Abstract][Full Text] [Related]
31. Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met. Chen T; Cai SL; Li J; Qi ZP; Li XQ; Ye LC; Xie XF; Hou YY; Yao LQ; Xu MD; Zhou PH; Xu JM; Zhong YS Sci Rep; 2017 Mar; 7():44543. PubMed ID: 28291253 [TBL] [Abstract][Full Text] [Related]
32. Functional expression of HGF and its receptor in human colorectal cancer. Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K Digestion; 2000; 61(4):237-46. PubMed ID: 10878450 [TBL] [Abstract][Full Text] [Related]
33. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma. Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649 [TBL] [Abstract][Full Text] [Related]
34. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma. Gao M; Zhang X; Li D; He P; Tian W; Zeng B Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907 [TBL] [Abstract][Full Text] [Related]
35. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Herynk MH; Tsan R; Radinsky R; Gallick GE Clin Exp Metastasis; 2003; 20(4):291-300. PubMed ID: 12856716 [TBL] [Abstract][Full Text] [Related]
36. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways. Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643 [TBL] [Abstract][Full Text] [Related]
37. JC virus mediates invasion and migration in colorectal metastasis. Link A; Shin SK; Nagasaka T; Balaguer F; Koi M; Jung B; Boland CR; Goel A PLoS One; 2009 Dec; 4(12):e8146. PubMed ID: 19997600 [TBL] [Abstract][Full Text] [Related]
38. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors. Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708 [TBL] [Abstract][Full Text] [Related]
39. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer. Parizadeh SM; Jafarzadeh-Esfehani R; Fazilat-Panah D; Hassanian SM; Shahidsales S; Khazaei M; Parizadeh SMR; Ghayour-Mobarhan M; Ferns GA; Avan A IUBMB Life; 2019 Jul; 71(7):802-811. PubMed ID: 31116909 [TBL] [Abstract][Full Text] [Related]
40. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]